Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Nidanilimab |
Trade Name | |
Synonyms | CAN04|CAN 04|CAN-04|Nadunolimab |
Drug Descriptions |
Nidanilimab is a humanized monoclonal antibody that targets ll1rap, which inhibits downstream signaling and blocks activation of NFkappa-B, thereby potentially inducing antibody-dependent cellular cytotoxicity, leading to decreased proliferation and increased death of tumor cells expressing IL1RAP (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | 2171061-85-9 |
NCIT ID | C153375 |